| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |